Flatrock Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Flatrock Wealth Partners's LLY Position: Q3 2026 in Review
Flatrock Wealth Partners increased its Eli Lilly (LLY) stake by 2.2% in Q3 2026, buying an estimated $21.2K and bringing the position to 834 shares worth $965K. The position accounts for 0.33% of the portfolio, ranked #50.
Flatrock Wealth Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $978K in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Flatrock Wealth Partners held 834 shares of Eli Lilly worth $965K as of Q3 2026.
- Flatrock Wealth Partners bought 18 Eli Lilly shares in Q3 2026, an estimated $21.2K.
- Eli Lilly made up 0.33% of Flatrock Wealth Partners's portfolio in Q3 2026, its #50 holding.
- Flatrock Wealth Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Flatrock Wealth Partners's Eli Lilly position peaked at $978K in Q2 2026.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Flatrock Wealth Partners's 13F filing for Q3 2026, filed 12 Nov 2026.